Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.7990
+0.0160 (2.04%)
At close: Feb 13, 2026, 4:00 PM EST
0.7760
-0.0230 (-2.88%)
After-hours: Feb 13, 2026, 6:16 PM EST
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $8.79 million as of February 13, 2026. Its market cap has decreased by -60.64% in one year.
Market Cap
8.79M
Enterprise Value
8.16M
1-Year Change
-60.64%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $8.79M, a decrease of -80.03%. That is a compound annual growth rate of -77.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.79M | -3.08% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.09B |
| Johnson & Johnson | 586.54B |
| AbbVie | 409.15B |
| AstraZeneca | 319.57B |
| Pulmatrix | 8.89M |
| NuCana | 8.82M |
| Ernexa Therapeutics | 8.75M |
| SeaStar Medical Holding | 8.65M |